GTx
About:
At GTx, They focus on the development of small molecules that selectively modulate the effects of certain hormones produced by the body.
Website: http://www.gtxinc.com
Twitter/X: capesaris
Top Investors: Biotechnology Value Fund, Boxer Capital, Abingworth, Aisling Capital, Amzak Capital Management
Description:
GTx, Inc. is a company of pioneering and driven individuals who are delivering better medicines with new science through established pathways.
Total Funding Amount:
$163M
Estimated Revenue Range:
Less than $1M
Headquarters Location:
Memphis, Tennessee, United States
Founded Date:
1997-01-01
Contact Email:
investor.relations(AT)gtxinc.com
Founders:
Andrew Romans, Mitchell Steiner
Number of Employees:
51-100
Last Funding Date:
2017-09-26
IPO Status:
Delisted
Industries:
© 2025 bioDAO.ai